Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl Cysteine in Preventing Contrast Induced Nephropathy
NCT01820195Phase 3Unknown
- Sponsor
- Imam Khomeini Hospital Complex
- Start
- Mar 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in contrast-induced nephropathy (CIN), sponsored by Imam Khomeini Hospital Complex. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01820195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01820195.